Back
Lucid Group Vs. United Therapeutics Industry Stock Comparison
Sell
37
LCID
Lucid Group
Last Price:
3.78
Seasonality Move:
0.13%
Buy
52
UTHR
United Therapeutics
Last Price:
344.85
Seasonality Move:
3.11%
Sell
37
Lucid Group (LCID)
is a Sell
Is Lucid Group a Buy, Sell or Hold?
- The current Lucid Group [LCID] share price is $3.77. The Score for LCID is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- LCID is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy, Sell or Hold?
- The current United Therapeutics [UTHR] share price is $344.98. The Score for UTHR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LCID Stock Price Chart
What is Lucid Group's stock price today?
-
The Lucid Group share price today is $3.77
The current trend is moderately bullish and LCID is experiencing selling pressure, which indicates risk of future bearish movement.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $344.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LCID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 53.09 | Buy |
| Chaikin Money Flow: | -19965344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.27 - 4.03) | Buy |
| Bollinger Bands (100): | (2.63 - 3.61) | Buy |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.68 | Buy |
| Relative Strength Index (14 RSI): | 52 | Buy |
| Chaikin Money Flow: | 321097 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (333.15 - 355.75) | Buy |
| Bollinger Bands (100): | (273.25 - 342.17) | Buy |
LCID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.72 | Buy |
| 20-day SMA: | 3.79 | Sell |
| 50-day SMA: | 3.52 | Buy |
| 200-day SMA: | 3.24 | Buy |
| 8-day EMA: | 3.8 | Sell |
| 20-day EMA: | 3.72 | Buy |
| 50-day EMA: | 3.49 | Buy |
| 200-day EMA: | 3.74 | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 344.81 | Buy |
| 20-day SMA: | 349.3 | Sell |
| 50-day SMA: | 336.35 | Buy |
| 200-day SMA: | 268.54 | Buy |
| 8-day EMA: | 344.94 | Buy |
| 20-day EMA: | 344.64 | Buy |
| 50-day EMA: | 333.24 | Buy |
| 200-day EMA: | 284.67 | Buy |
Lucid Group Earnings Growth & LCID Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.23 per share, and an increase next year of $0.25 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.72 per share, and an increase next year of $1.85 per share.
Lucid Group Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||